Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:e63-e67

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pietzsch, J.
Right arrow Articles by Julius, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pietzsch, J.
Right arrow Articles by Julius, U.
Related Collections
Right arrow Pathophysiology
Right arrow Other arteriosclerosis
Right arrow Lipid and lipoprotein metabolism
Right arrow Oxidant stress
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:e63.)
© 2000 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Oxidation of Apolipoprotein B-100 in Circulating LDL Is Related to LDL Residence Time

In Vivo Insights From Stable-Isotope Studies

Jens Pietzsch; Peter Lattke; Ulrich Julius

From the Institute and Polyclinic of Clinical Metabolic Research (J.P., U.J.) and the Institute of Clinical Chemistry and Laboratory Medicine (P.L.), Medical Faculty, Technical University Dresden, Dresden, Germany.

Correspondence to Dr Jens Pietzsch, Institute and Polyclinic of Clinical Metabolic Research, Medical Faculty ‘Carl Gustav Carus,’ Technical University, Fetscherstrasse 74, D-01307 Dresden, Germany. E-mail julius{at}rcs.urz.tu-dresden.de

Abstract—5-Hydroxy-2-aminovaleric acid (HAVA) has been suggested to be a specific marker of oxidation of apolipoprotein (apo) B-100 proline (Pro) and arginine (Arg) side-chain residues in low density lipoprotein (LDL) in vitro. Here we describe the application of sensitive mass spectrometric techniques to the characterization of Pro/Arg-modified apoB-100 in LDL1 (Sf 7 to 12) and LDL2 (Sf 0 to 7) in vivo. We studied 7 subjects with familial defective apoB-100 (FDB) and 8 normolipidemic controls. In FDB subjects, the presence of a mutant apoB-100 (FDB3500Q) in LDL markedly reduced its affinity for the LDL receptor, leading to increased residence times (RTs) of LDL1 (65±21 versus 32±12 hours, P<0.005) and LDL2 (230±40 versus 53±7 hours, P<0.001) when compared with controls, as determined by stable-isotope turnover studies. LDL1 HAVA content was not different between the groups (FDB, 0.004±0.001 mol/mol apoB-100 versus controls, 0.003±0.001 mol/mol apoB-100, P=0.200). LDL2 HAVA content was higher in FDB subjects (0.374±0.088 versus 0.013±0.002 mol/mol apoB-100, P<0.001). In both groups, LDL2 HAVA was positively associated with LDL2 RT (FDB, r=0.893, P=0.003; controls, r=0.976, P=0.000) and negatively correlated with LDL2 {alpha}-tocopherol content (FDB, r=-0.929, P=0.003; controls, r=-0.903, P=0.002). No significant correlations could be found between LDL1 HAVA, LDL1 RT, and {alpha}-tocopherol, respectively. The low LDL1 HAVA content observed in both FDB and control groups was thought to be due to the relatively lower RT as well as the higher {alpha}-tocopherol content of these lipoproteins. In contrast, LDL2 seemed to be strongly prone to direct oxidation of apoB-100 in vivo. The longer these particles linger in the circulation, the more apoB-100 Pro/Arg residues become modified.


Key Words: familial defective apolipoprotein B-100 • lipoproteins • residence time • oxidation • atherosclerosis